Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication approved for attention deficit hyperactivity disorder in youngsters and grown-ups . In Canada, its access is strictly regulated by Health https://sandozlisdexamfetaminefo799635.free-blogz.com/90874442/lisdexamfetamine-in-canada-a-comprehensive-guide